Jackson Square Capital, Llc
Source: SEC Form 13F · as of Mar 2026Jackson Square Capital, Llc holds 12 biotech & pharma companies tracked by BioSniper, totaling $38.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$38.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 18,563 | $17.1M |
| MRKMerck & Co., Inc. | 34,967 | $4.2M |
| JNJJOHNSON & JOHNSON | 16,966 | $4.1M |
| BMYBRISTOL MYERS SQUIBB CO | 61,310 | $3.7M |
| ABBVAbbVie Inc. | 15,337 | $3.3M |
| GILDGILEAD SCIENCES, INC. | 18,785 | $2.6M |
| CRVSCorvus Pharmaceuticals, Inc. | 63,773 | $933K |
| ABTABBOTT LABORATORIES | 8,614 | $884K |
| MCKMcKesson Corporation | 657 | $569K |
| NVSNovartis AG | 3,600 | $550K |
| AMGNAMGEN INC | 1,278 | $450K |
| REGNREGENERON PHARMACEUTICALS, INC. | 527 | $407K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.